Cleared Traditional

S.C.M.T. PERFORATOR (K871087) - FDA 510(k) Clearance

Class I Obstetrics & Gynecology device.

K871087 · Salt Creek Medical Technologies · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1987
Decision
5d
Days
Class 1
Risk

K871087 is an FDA 510(k) clearance for the S.C.M.T. PERFORATOR. Classified as Amniotome (product code HGE), Class I - General Controls.

Submitted by Salt Creek Medical Technologies (Pinckney, US). The FDA issued a Cleared decision on March 23, 1987 after a review of 5 days - a notably fast clearance cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.4530 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Salt Creek Medical Technologies devices

Submission Details

510(k) Number K871087 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 1987
Decision Date March 23, 1987
Days to Decision 5 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
155d faster than avg
Panel avg: 160d · This submission: 5d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HGE Amniotome
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 884.4530
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.